Malignant hypoglycemia associated with a large mesenchymal tumor: Case report and review of the literature

Cancer Journal from Scientific American

Volumn 5, Issue 1, 1999, Pages 48-51

  Rose, Michal G ^a   Tallini, G ^a   Pollak, J ^a   Murren, J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hypoglycemia; Insulinlike growth factor; Solitary fibrous tumor

Indexed keywords

PREDNISONE; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER MORTALITY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; HEART TUMOR; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MESENCHYMOMA; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 0033046733     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zapf J. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res 1994;42: 20-26.
2. Daughaday WH, Emanuele MA, Brooks MH et al. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988;319:1434-1440.
3. Axelrod L, Ron D. Insulin-like growth factor II and the riddle of tumor-induced hypoglycemia [editorial]. N Engl J Med 1988;319: 1477-1478.
4. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320.
5. Le Roith D, Clemmons D, Nissley P et al. Insulin-like growth factors in health and disease (NIH conference). Ann Intern Med 1992;116:854-862.
6. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of the literature. Cancer 1981; 47:2678-2689.
7. Ron D, Powers AC, Pandian MR et al. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia. J Clin Endocrinol Metab 1989;68:701-706.
8. Roith DL. Insulin-like growth factors. N Engl J Med 1997;336: 633-640.
9. Baxter RC. Insulin-like growth factor binding proteins as gluco-regulators. Metabolism 1995;40[suppl 4]:12-17.
10. Zapf J, Futo E, Peter M et al. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 1992;90:2574-2584.
11. Baxter RC, Holman SR, Corbould A et al. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1995;80:2700-2708.
12. Hunter SJ, Daughaday WH, Callender ME et al. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clin Endocrinol 1994;41:397-401.
13. Agus MS, Katz LE, Satin-Smith M et al. Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone. J Pediatr 1995;127:403-407.
14. Teale JD, Marks V. Alleviation of non-islet cell tumour hypoglycaemia by growth hormone is associated with changes in IGF binding protein-3. Ann Clin Biochem 1993;29:314-323.
15. Schweichler M, Hennessey JV, Cole P et al. Hypoglycemia in pregnancy secondary to a non-islet cell tumor of the pleura and ectopic insulin-like growth factor II hormone production. Obstet Gynecol 1995;85:810-813.
16. Trivedi N, Mithal A, Sharma AK et al. Non-islet cell tumour induced hypoglycaemia with acromegaloid facial and acral swelling. Clin Endocrinol 1995;42:433-435.
17. Lengle SJ, Hecht ST, Link DP et al. Palliative embolization of fibrosarcoma for control of tumor-induced hypoglycemia. Cardiovasc Invervent Radiol 1995;18:255-258.